☰

Scott C. Grindrod, Ph.D. - Publications

Affiliations: 
2008 University of Virginia, Charlottesville, VA 
Tree Info Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Valenea A, Grindrod S, Jung M. Abstract A15: DNA damage response-targeted molecules for breast cancer therapy Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-A15  0.391
2018 Grindrod S, Velena A, Jung M. Abstract A178: Targeting the ATM-mediated DNA damage response pathway for cancer treatment Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A178  0.43
2017 Paydar I, Velena A, Grindrod S, Jung M. Abstract 5855: Radiosensitization of cervical cancer cells by HDAC inhibitors Cancer Research. 77: 5855-5855. DOI: 10.1158/1538-7445.Am2017-5855  0.355
2017 Grindrod S, Velena A, Jung M. Abstract 4054: Development of dual function small molecules as therapeutic agents for cancer treatment Cancer Research. 77: 4054-4054. DOI: 10.1158/1538-7445.Am2017-4054  0.467
2017 Nicholas N, Velena A, Grindrod S, Jung M. Abstract 3215: Therapeutic potential of dual-function small molecules for breast cancers Cancer Research. 77: 3215-3215. DOI: 10.1158/1538-7445.Am2017-3215  0.372
2016 Cordova A, Woodrick J, Grindrod S, Zhang L, Saygideger-Kont Y, Wang K, DeVito S, Daniele S, Paige M, Brown ML. Aminopeptidase P mediated targeting for breast tissue specific conjugate delivery. Bioconjugate Chemistry. PMID 26965452 DOI: 10.1021/Acs.Bioconjchem.5B00481  0.489
2014 Ma Y, Tomita Y, Preet A, Clarke R, Englund E, Grindrod S, Nathan S, De Oliveira E, Brown ML, Rosen EM. Small-molecule "BRCA1-mimetics" are antagonists of estrogen receptor-α. Molecular Endocrinology (Baltimore, Md.). 28: 1971-86. PMID 25264941 DOI: 10.1210/Me.2014-1146  0.676
2014 Hou S, Yi YW, Kang HJ, Zhang L, Kim HJ, Kong Y, Liu Y, Wang K, Kong HS, Grindrod S, Bae I, Brown ML. Novel carbazole inhibits phospho-STAT3 through induction of protein-tyrosine phosphatase PTPN6. Journal of Medicinal Chemistry. 57: 6342-53. PMID 24978112 DOI: 10.1021/Jm4018042  0.554
2012 Walls TH, Grindrod SC, Beraud D, Zhang L, Baheti AR, Dakshanamurthy S, Patel MK, Brown ML, MacArthur LH. Synthesis and biological evaluation of a fluorescent analog of phenytoin as a potential inhibitor of neuropathic pain and imaging agent. Bioorganic & Medicinal Chemistry. 20: 5269-76. PMID 22863530 DOI: 10.1016/J.Bmc.2012.06.042  0.58
2011 Grindrod S, Suy S, Fallen S, Eto M, Toretsky J, Brown ML. Effects of a fluorescent Myosin light chain phosphatase inhibitor on prostate cancer cells. Frontiers in Oncology. 1: 27. PMID 22655237 DOI: 10.3389/Fonc.2011.00027  0.559
2011 Kong Y, Jung M, Wang K, Grindrod S, Velena A, Lee SA, Dakshanamurthy S, Yang Y, Miessau M, Zheng C, Dritschilo A, Brown ML. Histone deacetylase cytoplasmic trapping by a novel fluorescent HDAC inhibitor. Molecular Cancer Therapeutics. 10: 1591-9. PMID 21697394 DOI: 10.1158/1535-7163.Mct-10-0779  0.556
2011 Yenugonda VM, Deb TB, Grindrod SC, Dakshanamurthy S, Yang Y, Paige M, Brown ML. Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells. Bioorganic & Medicinal Chemistry. 19: 2714-25. PMID 21440449 DOI: 10.1016/J.Bmc.2011.02.052  0.603
2010 Ringer L, Sirajuddin P, Yenugonda VM, Ghosh A, Divito K, Trabosh V, Patel Y, Brophy A, Grindrod S, Lisanti MP, Rosenthal D, Brown ML, Avantaggiati ML, Rodriguez O, Albanese C. VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells. Cancer Biology & Therapy. 10: 320-5. PMID 20574155 DOI: 10.4161/Cbt.10.4.12208  0.547
2010 Sheikh KD, Banerjee PP, Jagadeesh S, Grindrod SC, Zhang L, Paige M, Brown ML. Fluorescent epigenetic small molecule induces expression of the tumor suppressor ras-association domain family 1A and inhibits human prostate xenograft. Journal of Medicinal Chemistry. 53: 2376-82. PMID 20184324 DOI: 10.1021/Jm9011615  0.683
2010 Hans SK, Camara F, Altiti A, Martín-Montalvo A, Brautigan DL, Heimark D, Larner J, Grindrod S, Brown ML, Mootoo DR. Synthesis of C-glycoside analogues of beta-galactosamine-(1-->4)-3-O-methyl-D-chiro-inositol and assay as activator of protein phosphatases PDHP and PP2Calpha. Bioorganic & Medicinal Chemistry. 18: 1103-10. PMID 20079654 DOI: 10.1016/J.Bmc.2009.12.056  0.458
2008 Chinigo GM, Paige M, Grindrod S, Hamel E, Dakshanamurthy S, Chruszcz M, Minor W, Brown ML. Asymmetric synthesis of 2,3-dihydro-2-arylquinazolin-4-ones: methodology and application to a potent fluorescent tubulin inhibitor with anticancer activity. Journal of Medicinal Chemistry. 51: 4620-31. PMID 18610995 DOI: 10.1021/Jm800271C  0.734
2005 Brautigan DL, Brown M, Grindrod S, Chinigo G, Kruszewski A, Lukasik SM, Bushweller JH, Horal M, Keller S, Tamura S, Heimark DB, Price J, Larner AN, Larner J. Allosteric activation of protein phosphatase 2C by D-chiro-inositol-galactosamine, a putative mediator mimetic of insulin action. Biochemistry. 44: 11067-73. PMID 16101290 DOI: 10.1021/Bi0508845  0.683
Show low-probability matches.